The immune system uses many sensors to detect and report microbial invaders. Most of these sensors are associated with immune cells, but the extracellular matrix also seems to be essential for this sentinel duty.
expression was not detectable at the putative sites of lymph node and Peyer's patch anlagen in Rorc(γt) GFP/GFP embryos, which lack LTi cells. In favor of the hypothesis that the initiation of lymphoid organ development requires a critical cluster size, those LTi cells that are dispersed within lymph node anlagen do not colocalize with high expression of VCAM-1 and ICAM-1. LTi cells in the lymphoid organ anlagen do not proliferate, indicating that the accumulation of these cells is the result of active recruitment 1 . Chemokines are essential to this process, as mice deficient in CXCL13 show clusters of LTi cells only in the anlagen of cervical and mesenteric lymph nodes that actually develop in these mice 1 . More saliently, mice doubly deficient for CXCR5 and CCR7 lack all peripheral lymph nodes 11 . However, they develop mesenteric lymph nodes and some Peyer's patches that are structurally altered, indicating that additional, as-yetunknown factors can contribute to the recruitment of LTi cells in certain anatomical compartments.
The function of LTi cells in lymph node and Peyer's patch development is seen as the activation of mesenchymal cells through interaction of LTα 1 β 2 with the LTβR receptor. This view is based mainly on the observation that blocking of this interaction during embryogenesis largely abrogates lymph node and Peyer's patch development, resulting in a phenotype similar to those of mice deficient in LTα, LTβ, or the LTβR 12 . Moreover, the block in lymph node and Peyer's patch development of LTα-deficient mice could be overcome by application of an agonist antibody for the LTβR. However, application of the agonist antibody does not rescue the development of lymph nodes or Peyer's patches in mice deficient in RORγt 1 . This result indicates that LTi cells have additional functions and that their interaction with mesenchymal organizer cells might be more complex than previously assumed.
In summary, LTi cells are central in the initiation of lymph node and Peyer's patch development, as they deliver crucial signals for the development of lymph node and Peyer's patch anlagen. To gain further insight into the differentiation of LTi cells and the function of RORγt in lymphoid organ development, it will be necessary to identify ligand(s) and target genes of RORγt. It will be particularly useful to determine whether the ligand is systemically or locally expressed during fetal development. So far, RORγt is the only molecule to our knowledge that is expressed exclusively in LTi cells during fetal development. The technical approach used by Eberl et al. 1 of replacing a single splice variant of RORγ by GFP opens up intriguing possibilities in the study of RORγt function in vivo. RORγt-GFP should simplify the isolation and purification of LTi cells to study their gene and protein expression profile and will be especially useful in tracking these cells in in vivo imaging experiments.
A berrant regulation of inflammatory responsiveness in the gut, including that induced by microflora, may underlie the pathogenesis of inflammatory bowel diseases (IBDs). The use of probiotics (therapeutic administration of beneficial bacteria) for treating IBDs emphasizes the importance of microflora-host interactions in determining disease outcome. However, the key mechanisms involved in the suppression of inflammatory responses in the gut remain poorly defined. In this issue of Nature Immunology, Kelly et al. have identified an interesting mechanism by which Bacteroides thetaiotaomicron, a chief component of commensal gut microflora, helps limit inflammation 1 .
This finding provides new and important insights that could substantially expand our understanding of how inflammatory responses are regulated by epithelial cells in the gut.
The recognition of microbial agents by a multitude of evolutionarily conserved pattern-recognition receptors initiates inflammatory host responses. The typical host response to bacteria is one of self-defense, characterized by the induction of inflammatory mediators that serve to kill or limit dissemination of these microbes. The gastrointestinal tract is unique in its ability to harbor commensal and nonvirulent bacterial strains without induction of uncontrolled inflammation. Indeed, many bacterial species resident in the gut have established a symbiotic relationship with the host. Notably, these bacteria have many of the same molecular patterns that would otherwise be expected to induce inflammation, yet exceedingly large numbers of these bacteria persist without an overt inflammatory response. This cannot be because of physical barriers alone, as global transcriptional studies show that commensal bacteria actively modulate gene expression in the host 2 .
The mammalian NF-κB transcription factors are key in regulating inflammatory and immune responses. The recognition of microbial agents by pattern-recognition receptors, such as members of the Toll-like receptor (TLR) family, initiates signaling cascades that lead to the activation of NF-κB. Nuclear NF-κB induces the transcription of many proinflammatory genes, including those encoding cytokines, chemokines and adhesion molecules.
Nonvirulent salmonella species are already known to prevent NF-κB activation in epithelial cells, the key contact point between microflora and the host 3 . Dimeric complexes of the five known NF-κB proteins are typically present in association with inhibitory IκB proteins (such as IκBα) in the cytoplasm (Fig. 1) .
After receiving an activation signal, IκB proteins are phosphorylated by IκB kinases IKKα and IKKβ, which leads to IκB ubiquitination followed by 26S proteasome-mediated degradation. 'Free' NF-κB dimers can then translocate to the nucleus and activate target genes, including those encoding proinflammatory molecules. Exposure of gut epithelial cells to nonvirulent salmonella strains prevents ubiquitination of IκBα induced by virulent salmonella strains or the proinflammatory cytokine tumor necrosis factor, probably by inhibiting the E3-SCF β-TrCP ubiquitination complex 3 . Consequently, this prevents IκBα degradation and NF-κB translocation to the nucleus. However, signal-induced phosphorylation of IκBα is unaffected. Although nonvirulent salmonella species are not commensal species, this previous study emphasized an important mechanism for regulating gut inflammation through the modulation of NF-κB activity that could potentially be used by commensal microflora as well.
In this issue of Nature Immunology, Kelly et al. have identified how a major species of gut commensal bacteria, Bacteroides thetaiotaomicron, could regulate inflammation. This additional mechanism also targets the NF-κB pathway in epithelial cells, but in a completely different manner from that of nonvirulent salmonella species. Kelly et al. show that the exposure of gut epithelial cells to B. thetaiotaomicron can remove nuclear NF-κB complexes induced by virulent salmonella strains. The crucial mechanism identified in this study involves a bacteroides-induced nuclear association between the NF-κB subunit RelA (p65) and the nuclear hormone receptor PPAR-γ. Subsequently, this newly formed complex is exported from the nucleus, resulting in the attenuation of NF-κB-mediated inflammatory gene expression (such as IL-8). Using small interfering RNA-mediated inhibition of PPAR-γ expression in epithelial cells, the authors were able to show a requirement for PPAR-γ in RelA nuclear export and in the attenuation of inflammatory gene expression. Although nuclear NF-κB activity has previously been shown to be regulated by nucleocytoplasmic shuttling, this study has identified an intriguing new function for PPAR-γ in this process. No obvious effect of PPAR-γ on IκBα ubiquitination (or phosphorylation and degradation) was noted, further indicating a mechanism distinct from that induced by nonvirulent salmonella species. Both the earlier study 3 and Kelly et al. used virulent salmonella strains as stimuli for NF-κB activation. Nonetheless, it is conceivable, and perhaps likely, that the NF-κB activation induced by the many species of commensal bacteria in the gut can also be inhibited in a similar way and thus help limit inflammation.
The PPAR-γ nuclear receptor itself is no stranger to the spotlight. Like NF-κB, this transcription factor has attracted the interest of investigators working in a variety of different areas. The ability of PPAR-γ to modulate NF-κB function has been documented before. Targeted disruption of the gene encoding PPAR-γ in mice (Pparg), which results in embryonic lethality, shows a key function for this nuclear receptor in the control of adipose tissue development. Studies with Pparg +/-mice have demonstrated an additional function in the regulation of highfat diet-induced adipocyte hypertrophy and in insulin resistance 4 . Other studies have suggested that PPAR-γ provides an anti-inflammatory function in macrophages 5, 6 . Using known PPAR-γ agonists, these studies indicate a function for PPAR-γ in the inhibition of NF-κB (and AP-1 and STAT) activation pathways in macrophages 5 . However, PPAR-γ agonists can also inhibit inflammatory gene expression in Pparg -/-macrophages, indicating that inhibition of NF-κB and/or other transcription factors in macrophages may not be PPAR-γ specific 7 . Perhaps the most compelling additional evidence of a function for PPAR-γ in regulating NF-κB comes from studies of Pparg +/-B cells 8 . Pparg +/-mice have exacerbated experimentally induced arthritis, as well as enhanced B cell proliferation 8 . Notably, Pparg +/-B cells show spontaneous NF-κB nuclear activity and an increase in LPS-induced NF-κB activation 8 . Thus, the increased NF-κB is due to an enhanced rate of IκBα phosphorylation. A normal function of PPAR-γ in B cells may be to limit NF-κB activation by inhibiting IκBα phosphorylation, presumably by directly or indirectly modulating the activity of IKK kinases. Figure 1 In the typical response to microbial pathogens (green), bacterial components are recognized by TLRs. Using multiple adaptor molecules and protein kinases, TLR engagement leads to activation of IKK kinases, which phosphorylate NF-κB p50-RelA heterodimer-associated IκB proteins. Phosphorylated IκB is targeted for polyubiquitination, followed by proteasome-mediated degradation. Free NF-κB dimers then translocate to nucleus and activate target gene expression. This typical NF-κB activation pathway can be inhibited by at least two different mechanisms in epithelial cells. Nonvirulent salmonella species (red) can inhibit IκB ubiquitination, thereby blocking IκB degradation and NF-κB translocation to the nucleus. The commensal bacterial species Bacteroides thetaiotaomicron (blue) does not interfere with NF-κB activation in the cytoplasm. Instead, these bacteria trigger association of the RelA subunit with the nuclear hormone receptor and transcription factor PPAR-γ. This newly formed complex is rapidly exported from the nucleus, thus attenuating expression of NF-κB-regulated inflammatory genes. The precise mechanism of nuclear export is still unknown. P, phosphorylation; Ub, ubiquitin. Together with the results of Kelly et al., it is apparent that PPAR-γ can inhibit NF-κB function by at least two distinct mechanisms. The relative use of these two mechanisms may depend on the cell type and and/or nature of the inducing agent. NF-κB association with PPAR-γ can inhibit PPAR-γ binding to DNA 9 . Thus, the interaction between these two transcription factors apparently results in mutual antagonism of function. More studies using mouse models are needed to further understand the in vivo function of PPAR-γ and NF-κB in regulating gut inflammation and in IBDs. Although PPAR-γ agonists can ameliorate colitis 10 , it is unclear whether the effects of agonists are PPAR-γ specific 7 . It is therefore important to determine whether Pparg +/-mice, which show distinct phenotypes despite having a functional allele 4, 8 , have heightened susceptibility to IBDs. This could be tested by studying these mice directly or after crossing them with mice known to be susceptible to IBD (such as IL-10-deficient mice). However, because IBDs involve the action of multiple cell types, it may be naive to assume that the function of NF-κB or PPAR-γ in epithelial cells alone will determine disease susceptibility of the whole organism. Thus, NF-κB-deficient mice (homozygously deficient in p50 and heterozygous for RelA deficiency) are more susceptible to helicobacter-induced colitis than are wild-type mice, probably because of enhanced IL-12 p40 production 11 .
Microbial suppression of host inflammatory and immune responses is a well documented phenomenon. Multiple virus-induced mechanisms have been described, ranging from inhibition of cell death to antagonism of cytokine-induced inflammatory pathways. For bacterial pathogens, a particularly apt example is the yersinia species, which include the agent of bubonic plague. A yersinia virulence factor, YopJ, inhibits multiple protein kinases involved in inflammatory responses, including those involved in NF-κB activation 12 . Thus, both viral and bacterial agents can enhance their virulence by inhibiting key host signaling pathways. In the examples discussed here, it is apparent that commensal and nonvirulent bacteria can also use similar strategies, but to the substantial benefit of the host. Given the central function of NF-κB is regulating innate immunity, it is not unexpected that many bacterial species have evolved specific mechanisms for inhibiting this transcription factor. As recent studies indicate, it is likely that additional mechanisms by which bacteria influence host biology will be discovered in the future.
It is also important to consider how the anti-inflammatory effect of commensal bacteria is balanced by the need of the host to induce a strong inflammatory response when confronted with virulent bacteria in the gut. One possibility is that proinflammatory signals received from a sufficiently large number of virulent bacteria can override the anti-inflammatory effect of commensal bacteria. However, to better define such cross-regulating pathways, it is crucial to identify the bacterial molecules responsible for anti-inflammatory effects on epithelial cells and to determine how host factors (such as NF-κB and PPAR-γ) are regulated by these molecules. As evidence of the involvement of microflora in IBDs continues to grow, it is increasingly important to understand how microbes regulate the inflammatory state of the gut and whether these regulatory mechanisms are impaired in individuals with IBDs. The findings of Kelly et al. certainly provide a strong starting point for such future studies.
T he ability to recognize and respond to microbial invaders is central to the body's immune response. The immune system has devised many ways to recognize, neutralize and destroy pathogens. The front line of this defense includes proteins called pattern-recognition receptors (PRRs) that bind to microbes or microbial pathogens, which triggers immune cells to ingest and destroy the pathogen. PRRs are found outside the cell in the extracellular matrix or serum and on the cell surface, as well as inside cells. The coordinated actions of these different PRRs result in an effective immune response to the invaders. Recent work in this area has focused mainly on PRRs expressed on the cell surface or intracellularly [1] [2] [3] [4] . In this issue of Nature Immunology, He et al. 5 remind us that PRRs in the extracellular matrix are also an essential line of defense against bacteria.
Most PRRs recognize conserved motifs found in microbes, called pathogen-associated molecular patterns (PAMPs). PAMPs include components of the microbial cell wall such as lipopolysaccharide (LPS) and lipoteichoic acid, as well as internal structures like bacterial DNA (CpG). PRRs can act to enhance the binding of PAMPs to cell surface receptors, to activate inflammatory responses or to induce phagocytosis of the microbe, or to effect a combination of these actions [1] [2] [3] [4] . Some PRRs recognize very specific PAMPs, such as the recognition of flagellin by Toll-like receptor 5 (TLR5), whereas others have a broad specificity of recognition, such as the binding of scavenger receptors to many different proteoglycan and lipid-containing PAMPs.
Extracellular proteins involved in microbe recognition include the serum proteins mannose-binding lectin and C-reactive protein, as well as the extracellular matrix components fibronectin and collagen. Cell surface PRRs include proteins that stimulate the phagocytosis of microbes (such as scavenger receptors) and receptors involved in generating an
